Find Clinical Trial

Home » Find Clinical Trials » Assessment of blood glucose profile in type 2 diabetic patients after a one-week treatment with gliclazide 60 mg MR using both the glycaemic Holter method and multiple blood glucose samples. A double-blind, randomized, parallel group, placebo-controlled, exploratory study.

Assessment of blood glucose profile in type 2 diabetic patients after a one-week treatment with gliclazide 60 mg MR using both the glycaemic Holter method and multiple blood glucose samples. A double-blind, randomized, parallel group, placebo-controlled, exploratory study.

← Back

Study Phase	Phase 2

Therapeutic Area	Metabolism

Indication	Diabetes - Type II

Sponsor	Institut de Recherches Internationales Servier (I.R.I.S)

Active substance/ Medical device	GLICLAZIDE

Active Substance Code	DIABE

Protocol Code	CL2-DIABE-001

EudraCT Code	2008-002647-16

Documents and links

Results summary	READ MORE

Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.